| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | ||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net income | ||||||
1,069 | 668 | -941 | 1,115 | 318 | ||
Adjustments to reconcile net income to net cash used in operating activities: | ||||||
Interest income retained in Trust Account | ||||||
-1,822 | -1,393 | -1,745 | -1,855 | -530 | ||
Changes in operating assets and liabilities: | ||||||
Increase in prepaid expenses | ||||||
56 | -14 | -44 | -34 | 142 | ||
Increase in accounts payable | ||||||
7 | 33 | -8 | 16 | 5 | ||
Increase in accrued liabilities | ||||||
50 | 80 | 1,992 | -47 | 91 | ||
Increase in deferred compensation | ||||||
35 | - | - | - | - | ||
Increase in accrued income and franchise taxes and rounding | ||||||
394 | - | 38 | -90 | 117 | ||
Net cash used in operating activities | ||||||
-323 | -628 | -585 | -781 | -141 | ||
Cash flows from investing activities: | ||||||
Cash deposited in Trust Account | ||||||
- | 0 | 0 | 0 | 303,152 | ||
Cash flows from financing activities: | ||||||
Proceeds from sale of stock to Anchor Investor | ||||||
- | 0 | 0 | 0 | 3 | ||
Proceeds from Note payable to Sponsor | ||||||
- | 0 | 0 | 0 | 210 | ||
Proceeds from sale of Units to the public | ||||||
- | 0 | 0 | 0 | 300,150 | ||
Proceeds from sale of Private Placement Warrants | ||||||
- | 0 | 0 | 0 | 13,582 | ||
Payment of underwriting discounts | ||||||
- | 0 | 0 | 0 | 7,830 | ||
Payment of offering costs | ||||||
- | 1 | 0 | 44 | 702 | ||
Payment of Note payable to Sponsor | ||||||
- | 0 | 0 | 0 | 300 | ||
Net cash provided by financing activities | ||||||
- | -1 | 0 | -44 | 305,113 | ||
Net increase (decrease) in cash | ||||||
-323 | -179 | -218 | -305 | 1,820 | ||
Supplemental disclosure of non-cash financing activities: | ||||||
Deferred underwriters' compensation | ||||||
- | 0 | 0 | 0 | 10,179 | ||
Offering costs included in accounts payable | ||||||
- | - | - | - | 48 | ||